We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
-15.9%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$2.49B
AUM Growth
-$656M
Cap. Flow
-$84.6M
Cap. Flow %
-3.39%
Top 10 Hldgs %
39.14%
Holding
242
New
12
Increased
27
Reduced
100
Closed
17

Top Buys

Rank Stock Value
1
SHW icon
Sherwin-Williams
SHW
+$27M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$10.1M
3
WAT icon
Waters Corp
WAT
+$6.41M
4
EPD icon
Enterprise Products Partners
EPD
+$3.16M
5
LH icon
Labcorp
LH
+$3.14M

Top Sells

Rank Stock Value
1
MDR
McDermott International
MDR
+$30.5M
2
SLB icon
SLB Ltd
SLB
+$24.4M
3
LBTYA icon
Liberty Global Class A
LBTYA
+$12.9M
4
QCOM icon
Qualcomm
QCOM
+$11.1M
5
MSFT icon
Microsoft
MSFT
+$7.5M

Sector Composition

Rank Sector Weight
1 Financials 30.05%
2 Healthcare 18.3%
3 Technology 12.11%
4 Communication Services 10.64%
5 Industrials 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DD icon
126
DuPont de Nemours
DD
$18.6B
$756K 0.03%
5,582
– –
NVS icon
127
Novartis
NVS
$302B
$734K 0.03%
9,542
– –
KKR icon
128
KKR & Co
KKR
$89.1B
$721K 0.03%
36,750
-43,100
-54% -$986K
IDXX icon
129
Idexx Laboratories
IDXX
$44.9B
$694K 0.03%
3,730
-200
-5% -$41K
UNH icon
130
UnitedHealth
UNH
$382B
$692K 0.03%
2,777
-221
-7% -$58.4K
CSL icon
131
Carlisle Companies
CSL
$13.5B
$673K 0.03%
6,700
– –
CHCO icon
132
City Holding Co
CHCO
$2.05B
$666K 0.03%
9,860
– –
GLW icon
133
Corning
GLW
$107B
$662K 0.03%
21,905
– –
UN
134
DELISTED
Unilever NV New York Registry Shares
UN
$605K 0.02%
11,250
– –
WBA
135
DELISTED
Walgreens Boots Alliance
WBA
$582K 0.02%
8,513
-475
-5% -$36.8K
TSCO icon
136
Tractor Supply
TSCO
$16.3B
$572K 0.02%
34,255
-600
-2% -$10.8K
ADP icon
137
Automatic Data Processing
ADP
$109B
$571K 0.02%
4,351
– –
EMR icon
138
Emerson Electric
EMR
$81.6B
$560K 0.02%
9,370
-2,400
-20% -$162K
SO icon
139
Southern Company
SO
$108B
$536K 0.02%
12,200
– –
FTV icon
140
Fortive
FTV
$18.2B
$530K 0.02%
12,420
-108
-0.9% -$5.07K
FLS icon
141
Flowserve
FLS
$8.94B
$508K 0.02%
13,362
– –
GE icon
142
GE Aerospace
GE
$364B
$502K 0.02%
13,843
-13,499
-49% -$609K
SUBC
143
DELISTED
SUBSEA 7 S A SPONSORED ADR
SUBC
$491K 0.02%
50,454
-37,346
-43% -$363K
CELG
144
DELISTED
Celgene Corp
CELG
$464K 0.02%
7,237
– –
TMM
145
DELISTED
GRUPO TMM S.A.B. ADS REPTG FIVE ORD PART CERT SER A SH
TMM
$460K 0.02%
321,700
-5,300
-2% -$7.58K
IRM icon
146
Iron Mountain
IRM
$35.9B
$458K 0.02%
14,124
-719
-5% -$23.6K
TMO icon
147
Thermo Fisher Scientific
TMO
$214B
$453K 0.02%
2,025
– –
GIS icon
148
General Mills
GIS
$20.2B
$433K 0.02%
11,125
– –
MKC icon
149
McCormick & Company Non-Voting
MKC
$14B
$420K 0.02%
6,034
-450
-7% -$32.3K
SCHH icon
150
Schwab US REIT ETF
SCHH
$11.7B
$419K 0.02%
+21,778
New +$445K
4 5
6
7 8

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q4 2018 Portfolio in Review

As of Q4 2018, Beck Mack & Oliver held 242 positions worth $2.49B, down 21% from $3.15B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Beck Mack & Oliver withdrew a net $84.6M in Q4 2018, closing 17 positions and reducing 100 holdings. Its most notable exit was McDermott International, an estimated $30.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Beck Mack & Oliver opened a new position in Sherwin-Williams worth $26.3M.

  • Beck Mack & Oliver's largest Q4 2018 buy was Sherwin-Williams: 200,220 shares worth $26.3M.
  • Beck Mack & Oliver added most to Teva Pharmaceuticals in Q4 2018, an estimated $10.1M increase.
  • Beck Mack & Oliver's biggest Q4 2018 reduction was SLB Ltd, cutting an estimated $24.4M.
  • Beck Mack & Oliver fully exited McDermott International in Q4 2018, selling an estimated $30.5M.
  • Beck Mack & Oliver's ten largest holdings make up 39% of its $2.49B portfolio in Q4 2018.
  • Beck Mack & Oliver opened 12 new positions and closed 17 in Q4 2018.
  • Beck Mack & Oliver's portfolio value fell 21% quarter-over-quarter to $2.49B.

Based on Beck Mack & Oliver's 13F filing for Q4 2018, filed 4 Feb 2019.